Literature DB >> 11471341

Sinus disease in cystic fibrosis.

G K Mak1, N R Henig.   

Abstract

Entities:  

Mesh:

Year:  2001        PMID: 11471341     DOI: 10.1385/CRIAI:21:1:51

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


× No keyword cloud information.
  32 in total

1.  Topical use of antibiotics for paranasal sinusitis.

Authors:  T Kobayashi; S Baba
Journal:  Rhinol Suppl       Date:  1992

2.  Patterns of sinusitis in cystic fibrosis.

Authors:  V G Gentile; G Isaacson
Journal:  Laryngoscope       Date:  1996-08       Impact factor: 3.325

3.  Management of sinusitis in adult cystic fibrosis.

Authors:  S C Marks; D G Kissner
Journal:  Am J Rhinol       Date:  1997 Jan-Feb

Review 4.  The diagnosis of cystic fibrosis.

Authors:  R C Stern
Journal:  N Engl J Med       Date:  1997-02-13       Impact factor: 91.245

5.  Maxillary sinusitis as a surrogate model for CF gene therapy clinical trials in patients with antrostomies.

Authors:  J A Wagner; I B Nepomuceno; N Shah; A H Messner; M L Moran; A M Norbash; R B Moss; J J Wine; P Gardner
Journal:  J Gene Med       Date:  1999 Jan-Feb       Impact factor: 4.565

Review 6.  Utility of the nasal model in gene transfer studies in cystic fibrosis.

Authors:  S M Graham; J L Launspach
Journal:  Rhinology       Date:  1997-12       Impact factor: 3.681

7.  Prophylactic antibiotic therapy is associated with an increased prevalence of Aspergillus colonization in adult cystic fibrosis patients.

Authors:  J Bargon; N Dauletbaev; B Köhler; M Wolf; H G Posselt; T O Wagner
Journal:  Respir Med       Date:  1999-11       Impact factor: 3.415

8.  Pathological changes of the lateral nasal wall in patients with cystic fibrosis (mucoviscidosis).

Authors:  P Brihaye; P A Clement; I Dab; B Desprechin
Journal:  Int J Pediatr Otorhinolaryngol       Date:  1994-01       Impact factor: 1.675

9.  Treatment and prognosis of nasal polyps in cystic fibrosis.

Authors:  R C Stern; T F Boat; R E Wood; L W Matthews; C F Doershuk
Journal:  Am J Dis Child       Date:  1982-12

10.  Management of sinusitis in cystic fibrosis by endoscopic surgery and serial antimicrobial lavage. Reduction in recurrence requiring surgery.

Authors:  R B Moss; V V King
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1995-05
View more
  6 in total

Review 1.  Cystic fibrosis chronic rhinosinusitis: a comprehensive review.

Authors:  Mohamad R Chaaban; Alexandra Kejner; Steven M Rowe; Bradford A Woodworth
Journal:  Am J Rhinol Allergy       Date:  2013 Sep-Oct       Impact factor: 2.467

2.  Prevalence of rhinosinusitis among atypical cystic fibrosis patients.

Authors:  Tal Marshak; Y Rivlin; L Bentur; O Ronen; N Uri
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-09-15       Impact factor: 2.503

3.  Sinonasal characteristics and quality of life by SNOT-22 in adult patients with cystic fibrosis.

Authors:  Suzie Hyeona Kang; Camila Degen Meotti; Karine Bombardelli; Otávio Bejzman Piltcher; Paulo de Tarso Roth Dalcin
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-18       Impact factor: 2.503

4.  T2R38 genotype is correlated with sinonasal quality of life in homozygous ΔF508 cystic fibrosis patients.

Authors:  Nithin D Adappa; Alan D Workman; Denis Hadjiliadis; Daniel J Dorgan; Danielle Frame; Steven Brooks; Laurel Doghramji; James N Palmer; Corrine Mansfield; Danielle R Reed; Noam A Cohen
Journal:  Int Forum Allergy Rhinol       Date:  2015-12-17       Impact factor: 3.858

Review 5.  Chronic rhinosinusitis and nasal polyposis in cystic fibrosis: update on diagnosis and treatment.

Authors:  Suzie Hyeona Kang; Paulo de Tarso Roth Dalcin; Otavio Bejzman Piltcher; Raphaella de Oliveira Migliavacca
Journal:  J Bras Pneumol       Date:  2015 Jan-Feb       Impact factor: 2.624

6.  Sinonasal inhalation of tobramycin vibrating aerosol in cystic fibrosis patients with upper airway Pseudomonas aeruginosa colonization: results of a randomized, double-blind, placebo-controlled pilot study.

Authors:  Jochen G Mainz; Katja Schädlich; Claudia Schien; Ruth Michl; Petra Schelhorn-Neise; Assen Koitschev; Christiane Koitschev; Peter M Keller; Joachim Riethmüller; Baerbel Wiedemann; James F Beck
Journal:  Drug Des Devel Ther       Date:  2014-02-10       Impact factor: 4.162

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.